HLA Antibodies in Systemic Lupus Erythematosus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens
About this trial
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.
Eligibility criteria
Qualifiers
Patients Adults
Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
With sera stored in the biobank
Disqualifiers
minor Patients
Opposing the re-use of their personal data for research purposes
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov